South African study adds more evidence Omicron is less severe, only partly vaccine-resistant

South Africa vaccination site
(Image credit: Rodger Bosch/AFP/Getty Images)

COVID-19's Omicron variant continues to spread around the U.S. and the world, and the World Health Organization on Monday deemed it a "very high" global risk. But a study released Tuesday by Discovery Health, South Africa's largest health insurer, offered more evidence that the new coronavirus strain causes milder illness, even as it evades some of the protections from the Pfizer-BioNTech vaccine.

The study examined 211,000 positive COVID-19 cases, including 78,000 South Africans who contracted the Omicron variant. It found that hospital admissions are 29 percent lower among adults infected with the Omicron than in the first wave of the pandemic back in mid-2000, and those hospitalized had less serious symptoms. .

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us
Peter Weber, The Week US

Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.